D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTD
3201
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $237K | ﹤0.01% |
18,186
-249
| -1% | -$3.96K |
|
3202
PUT
B&G Foods
BGS
$285M
| $236K | ﹤0.01% |
+7,400
| New | +$243K |
|
3203
CALL
Primerica
PRI
$9.81B
| $236K | ﹤0.01% |
2,900
-700
| -19% | -$54.7K |
|
|
VIVS
3204
VivoSim Labs
VIVS
$1.46M
| $236K | ﹤0.01% |
+443
| New | +$236K |
|
3205
Apogee Enterprises
APOG
$850M
| $235K | ﹤0.01% |
+4,862
| New | +$239K |
|
3206
Regions Financial
RF
$26.3B
| $235K | ﹤0.01% |
15,400
-2,798
| -15% | -$40.2K |
|
|
OPTU
3207
Optimum Communications Inc
OPTU
$316M
| $234K | ﹤0.01% |
8,551
-13,949
| -62% | -$426K |
|
3208
PUT
MSCI
MSCI
$40B
| $234K | ﹤0.01% |
+2,000
| New | +$222K |
|
3209
Atlantic Union Bankshares
AUB
$5.99B
| $231K | ﹤0.01% |
6,555
-15,272
| -70% | -$492K |
|
3210
CEMIG Preferred Shares
CIG
$6.09B
| $231K | ﹤0.01% |
182,589
+80,416
| +79% | +$110K |
|
3211
Horace Mann Educators
HMN
$2.1B
| $231K | ﹤0.01% |
5,882
-200
| -3% | -$7.37K |
|
|
NGD
3212
DELISTED
New Gold Inc
NGD
| $231K | ﹤0.01% |
62,332
+3,865
| +7% | +$13.3K |
|
3213
CALL
Allstate
ALL
$66.9B
| $230K | ﹤0.01% |
2,500
| – | – |
|
3214
CALL
Box
BOX
$4.02B
| $230K | ﹤0.01% |
+11,900
| New | +$224K |
|
3215
MGE Energy Inc
MGEE
$3.11B
| $230K | ﹤0.01% |
3,557
-5,754
| -62% | -$372K |
|
3216
PUT
Kodak
KODK
$806M
| $229K | ﹤0.01% |
31,100
-18,900
| -38% | -$157K |
|
|
QTRH
3217
DELISTED
Quarterhill Inc. Common Shares
QTRH
| $229K | ﹤0.01% |
173,900
-5,700
| -3% | -$7.84K |
|
3218
Jack Henry & Associates
JKHY
$10.7B
| $228K | ﹤0.01% |
2,216
-4,252
| -66% | -$440K |
|
|
LUMO
3219
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $228K | ﹤0.01% |
2,492
-2,175
| -47% | -$167K |
|
3220
CytomX Therapeutics
CTMX
$705M
| $227K | ﹤0.01% |
+12,483
| New | +$195K |
|
|
PHX
3221
DELISTED
PHX Minerals
PHX
| $226K | ﹤0.01% |
+9,500
| New | +$211K |
|
|
SLCA
3222
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $226K | ﹤0.01% |
7,278
-209,532
| -97% | -$6.07M |
|
3223
ICU Medical
ICUI
$3.93B
| $224K | ﹤0.01% |
1,207
-1,833
| -60% | -$320K |
|
3224
Immunic
IMUX
$182M
| $224K | ﹤0.01% |
111
+4
| +4% | +$5.22K |
|
3225
Cartesian Therapeutics
RNAC
$232M
| $224K | ﹤0.01% |
+409
| New | +$218K |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.